What is Anika Therapeutics's net investment in lease?

Anika Therapeutics (ANIK) reported net investment in lease of $25.43M in Q1 2026.

How has Anika Therapeutics's net investment in lease changed year-over-year?

Anika Therapeutics's net investment in lease increased by 1.0% year-over-year, from $25.18M to $25.43M.

What is the long-term trend for Anika Therapeutics's net investment in lease?

Over 5 years (2020 to 2025), Anika Therapeutics's net investment in lease has grown at a 2.8% compound annual growth rate (CAGR), from $22.62M to $25.94M.

Anika Therapeutics ANIK Net Investment in Lease

Net Investment in Lease at other companies

VericelVCEL

——

Pacira BioSciences, Inc.PCRX

——

BioventusBVS

——

Xtant Medical HoldingsXTNT

——

Globus MedicalGMED

——

Organogenesis Holdings Inc.ORGO

——

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's net investment in lease?: Anika Therapeutics (ANIK) reported net investment in lease of $25.43M in Q1 2026.
How has Anika Therapeutics's net investment in lease changed year-over-year?: Anika Therapeutics's net investment in lease increased by 1.0% year-over-year, from $25.18M to $25.43M.
What is the long-term trend for Anika Therapeutics's net investment in lease?: Over 5 years (2020 to 2025), Anika Therapeutics's net investment in lease has grown at a 2.8% compound annual growth rate (CAGR), from $22.62M to $25.94M.